1. Investigation of Escherichia coli Harboring the mcr-1 Resistance Gene - Connecticut, 2016.
- Author
-
Vasquez AM, Montero N, Laughlin M, Dancy E, Melmed R, Sosa L, Watkins LF, Folster JP, Strockbine N, Moulton-Meissner H, Ansari U, Cartter ML, and Walters MS
- Subjects
- Caribbean Region, Connecticut, Escherichia coli drug effects, Escherichia coli Infections diagnosis, Feces microbiology, Humans, Polymyxins pharmacology, Travel, Drug Resistance, Bacterial genetics, Escherichia coli genetics, Escherichia coli isolation & purification, Escherichia coli Infections microbiology
- Abstract
The mcr-1 gene confers resistance to the polymyxins, including the antibiotic colistin, a medication of last resort for multidrug-resistant infections. The mcr-1 gene was first reported in 2015 in food, animal, and patient isolates from China (1) and is notable for being the first plasmid-mediated colistin resistance mechanism to be identified. Plasmids can be transferred between bacteria, potentially spreading the resistance gene to other bacterial species. Since its discovery, the mcr-1 gene has been reported from Africa, Asia, Europe, South America, and North America (2,3), including the United States, where it has been identified in Escherichia coli isolated from three patients and from two intestinal samples from pigs (2,4-6). In July 2016, the Pathogen Detection System at the National Center for Biotechnology Information (Bethesda, Maryland) identified mcr-1 in the whole genome sequence of an E. coli isolate from a Connecticut patient (7); this is the fourth isolate from a U.S. patient to contain the mcr-1 gene.
- Published
- 2016
- Full Text
- View/download PDF